Related Experiment Videos
Long-term results of "simple" thrombectomy for thrombosed Björk-Shiley aortic valve prostheses
Insights
Bjork-Shiley aortic valve thrombosis requires prompt surgical intervention for survival. Maintaining therapeutic warfarin anticoagulation is crucial for preventing recurrent valve thrombosis.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomaterials Science
Background:
- Bjork-Shiley aortic valves are prosthetic devices used to replace damaged aortic valves.
- Thrombosis, or clot formation, on these valves can lead to serious complications.
- Anticoagulation therapy is often necessary but can be challenging to manage effectively.
Purpose of the Study:
- To report on the incidence and outcomes of Bjork-Shiley aortic valve thrombosis.
- To emphasize the importance of early detection and surgical intervention.
- To evaluate the long-term efficacy of anticoagulation in preventing recurrence.
Main Methods:
- Retrospective review of 8 patients diagnosed with Bjork-Shiley aortic valve thrombosis over two years.
- Analysis of patient histories, anticoagulation management, and surgical outcomes.
- Assessment of hemodynamic improvement and complication rates post-intervention.
Main Results:
- Eight patients presented with Bjork-Shiley aortic valve thrombosis, representing a 4% incidence in one series.
- All patients experienced difficulties with anticoagulation therapy.
- Three patients died before surgical intervention could be performed.
- Surgical debridement of thrombi resulted in satisfactory immediate hemodynamic improvement and a two-year complication-free period for some patients.
Conclusions:
- Bjork-Shiley aortic valve thrombosis is a serious complication associated with anticoagulation challenges.
- Early diagnosis and emergency surgery are critical for patient survival.
- Effective anticoagulation with warfarin appears to be the primary method for preventing recurrent valve thrombosis.
Abstract:
During the past two years 8 patients were seen with thrombosis of their Bjork-Shiley aortic valves. Six patients were from our series, an incidence of 4% and 2 patients had their original valve implanted at another institution. All patients had substantial problems with anticoagulation therapy. Three died prior to operation. Early detection and emergency surgical intervention is mandatory for survival. At operation debridement of all thrombotic material from the valve provided satisfactory immediate hemodynamic improvements as well as freedom from complications for up to two years. Therapeutic levels of anticoagulation with warfarin are the only apparent protection from thrombosis of the Bjork-Shiley aortic valve.